17 HANOVER SQUARE, LONDON, X0
CFO Appointment - Thomas Freeburg Named Chief Financial Officer
Niki BioSolutions Enters At The Market Offering Agreement with Wainwright
Alidad Mireskandari, Ph.D. President & COO Global Investment Conference, September 2026
CEO and COO Appointments - Ian Huen and Alidad Mireskandari Named
Amended material disclosure
Operating and Financial Review and Prospects
Other Events
Provides Update on DiamiR Biosciences Merger
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
RW
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(3)
No filings found
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Post-Effective Amendment to Registration Statement
Delisting Amendment
Submission Upload
Correspondence